BR112012011576A2 - dna de minicírculos superenrolados para aplicações de terapia genética - Google Patents
dna de minicírculos superenrolados para aplicações de terapia genéticaInfo
- Publication number
- BR112012011576A2 BR112012011576A2 BR112012011576A BR112012011576A BR112012011576A2 BR 112012011576 A2 BR112012011576 A2 BR 112012011576A2 BR 112012011576 A BR112012011576 A BR 112012011576A BR 112012011576 A BR112012011576 A BR 112012011576A BR 112012011576 A2 BR112012011576 A2 BR 112012011576A2
- Authority
- BR
- Brazil
- Prior art keywords
- gene therapy
- supercoiled
- dna
- therapy applications
- mini
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/50—Methods for regulating/modulating their activity
- C12N2320/52—Methods for regulating/modulating their activity modulating the physical stability, e.g. GC-content
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
- C12N2330/51—Specially adapted vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25245509P | 2009-10-16 | 2009-10-16 | |
| PCT/US2010/052920 WO2011047318A2 (en) | 2009-10-16 | 2010-10-15 | Supercoiled minicircle dna for gene therapy applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012011576A2 true BR112012011576A2 (pt) | 2015-09-15 |
Family
ID=43876905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012011576A BR112012011576A2 (pt) | 2009-10-16 | 2010-10-15 | dna de minicírculos superenrolados para aplicações de terapia genética |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US8460924B2 (enExample) |
| EP (1) | EP2488641B1 (enExample) |
| JP (2) | JP2013507934A (enExample) |
| KR (1) | KR20120094166A (enExample) |
| AU (1) | AU2010306645B2 (enExample) |
| BR (1) | BR112012011576A2 (enExample) |
| CA (1) | CA2777835A1 (enExample) |
| MX (1) | MX2012004447A (enExample) |
| NZ (1) | NZ599998A (enExample) |
| WO (1) | WO2011047318A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101510830B1 (ko) | 2012-05-11 | 2015-04-10 | 가톨릭대학교 산학협력단 | 생리활성 단백질을 발현하는 미니서클을 이용하여 형질전환된 줄기세포를 통한 치료법 |
| WO2013181440A1 (en) * | 2012-05-30 | 2013-12-05 | Baylor College Of Medicine | Supercoiled minivectors as a tool for dna repair, alteration and replacement |
| EP2735614A1 (en) * | 2012-11-22 | 2014-05-28 | Centre National De La Recherche Scientifique | In vitro production of DNA minicircles comprising less than 250 base pairs |
| US10604771B2 (en) | 2013-05-10 | 2020-03-31 | Sangamo Therapeutics, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
| GB201702500D0 (en) * | 2017-02-16 | 2017-04-05 | Univ Sheffield | Stable vamp reporter assay |
| US20180305701A1 (en) | 2017-03-14 | 2018-10-25 | Baylor College Of Medicine | Targeting minivectors to specific tissue using shape |
| US20200048716A1 (en) | 2017-11-03 | 2020-02-13 | Twister Biotech, Inc | Using minivectors to treat ovarian cancer |
| WO2021055760A1 (en) | 2019-09-18 | 2021-03-25 | Intergalactic Therapeutics, Inc. | Synthetic dna vectors and methods of use |
| US20240100189A1 (en) | 2021-09-10 | 2024-03-28 | Twister Biotech, Inc | Using minivectors to treat idiopathic pulmonary fibrosis |
| US20240093226A1 (en) | 2021-09-10 | 2024-03-21 | Baylor College Of Medicine | Ultrapure minivectors for gene therapy |
| US20230190955A1 (en) | 2021-10-21 | 2023-06-22 | Baylor College Of Medicine | Treatment of liver cancer or liver fibrosis |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2626584B1 (fr) * | 1988-01-28 | 1990-07-13 | Agronomique Inst Nat Rech | Sequence ars efficace chez yarrowia lipolytica et procede pour sa preparation |
| WO1994009127A2 (en) | 1992-10-16 | 1994-04-28 | The Government Of The United States Of America As Represented By The Secretary, Department Of Healthand Human Services | Supercoiled minicircle dna as as a unitary promoter vector |
| US6964861B1 (en) * | 1998-11-13 | 2005-11-15 | Invitrogen Corporation | Enhanced in vitro recombinational cloning of using ribosomal proteins |
| EP2105496B1 (en) | 2000-12-08 | 2013-02-20 | Life Technologies Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| GB0108968D0 (en) * | 2001-04-10 | 2001-05-30 | Imp College Innovations Ltd | Methods |
| WO2002083889A2 (en) | 2001-04-10 | 2002-10-24 | Imperial College Innovations Limited | Methods for the production of minicircles |
| WO2003064623A2 (en) | 2002-01-31 | 2003-08-07 | Washington State University Research Foundation | Methods and vectors for facilitating site-specific recombination |
| AU2003273995A1 (en) | 2002-06-05 | 2003-12-22 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| EP2801614B1 (en) * | 2002-08-29 | 2019-05-15 | The Board of Trustees of the Leland Stanford Junior University | Circular nucleic acid vectors and methods for making and using the same |
| US7288529B2 (en) * | 2003-04-24 | 2007-10-30 | New York University | ALK protein tyrosine kinase, cells and methods embodying and using same |
| ATE340264T1 (de) * | 2003-06-10 | 2006-10-15 | Mologen Ag | Zirkuläres expressionskonstrukt für gentherapeutische anwendungen |
| AU2006204120A1 (en) * | 2005-01-06 | 2006-07-13 | Benitec, Inc. | RNAi agents for maintenance of stem cells |
| US7622252B2 (en) * | 2005-06-10 | 2009-11-24 | Baylor College Of Medicine | Generation of minicircle DNA with physiological supercoiling |
| WO2007130604A2 (en) * | 2006-05-04 | 2007-11-15 | Baylor Research Institute | Anti-tumor activity of an oncolytic adenovirus-delivered oncogene sirna |
| EP2178896A1 (en) | 2007-07-31 | 2010-04-28 | The Johns Hopkins University | Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
-
2010
- 2010-10-15 US US12/905,612 patent/US8460924B2/en active Active
- 2010-10-15 KR KR20127012633A patent/KR20120094166A/ko not_active Withdrawn
- 2010-10-15 BR BR112012011576A patent/BR112012011576A2/pt not_active IP Right Cessation
- 2010-10-15 WO PCT/US2010/052920 patent/WO2011047318A2/en not_active Ceased
- 2010-10-15 MX MX2012004447A patent/MX2012004447A/es active IP Right Grant
- 2010-10-15 US US13/502,162 patent/US8729044B2/en active Active
- 2010-10-15 CA CA 2777835 patent/CA2777835A1/en not_active Abandoned
- 2010-10-15 NZ NZ59999810A patent/NZ599998A/en not_active IP Right Cessation
- 2010-10-15 JP JP2012534410A patent/JP2013507934A/ja active Pending
- 2010-10-15 AU AU2010306645A patent/AU2010306645B2/en not_active Ceased
- 2010-10-15 EP EP10824202.5A patent/EP2488641B1/en active Active
-
2013
- 2013-04-30 US US13/873,737 patent/US9267150B2/en active Active
-
2016
- 2016-11-01 JP JP2016214390A patent/JP2017046710A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20110160284A1 (en) | 2011-06-30 |
| WO2011047318A2 (en) | 2011-04-21 |
| EP2488641A2 (en) | 2012-08-22 |
| US8729044B2 (en) | 2014-05-20 |
| US20130316449A1 (en) | 2013-11-28 |
| WO2011047318A3 (en) | 2011-09-09 |
| US20120302625A1 (en) | 2012-11-29 |
| MX2012004447A (es) | 2012-10-15 |
| JP2013507934A (ja) | 2013-03-07 |
| US9267150B2 (en) | 2016-02-23 |
| EP2488641A4 (en) | 2013-11-13 |
| EP2488641B1 (en) | 2019-01-23 |
| US8460924B2 (en) | 2013-06-11 |
| AU2010306645B2 (en) | 2017-03-23 |
| KR20120094166A (ko) | 2012-08-23 |
| NZ599998A (en) | 2014-11-28 |
| CA2777835A1 (en) | 2011-04-21 |
| AU2010306645A1 (en) | 2012-06-07 |
| WO2011047318A8 (en) | 2011-06-09 |
| JP2017046710A (ja) | 2017-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125236T1 (el) | Rna τροποποιημενου ακρου | |
| AR121761A2 (es) | Polipéptidos que presentan actividad de fosfolipasa y polinucleótidos que codifican los mismos | |
| IL261570B (en) | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | |
| EP2488641A4 (en) | SUPERGESPULED MINICIRCLE DNA FOR GENE THERAPY APPLICATIONS | |
| IN2014CN00650A (enExample) | ||
| GB2537077A (en) | Methods for sequencing nucleic acids | |
| BR112012015740A2 (pt) | anticorpos de anti-flt3 e metodos de uso dos mesmos | |
| DK4342987T3 (da) | Sammensætning til spaltning af et mål-dna omfattende et guide-rna specifikt for mål-dna'et og cas-protein-kodende nukleinsyre eller cas-protein, og anvendelser deraf | |
| BR112014032316A2 (pt) | proteínas de repetição de anquirina projetadas que se ligam ao fator de crescimento derivado de plaqueta | |
| CL2013001831A1 (es) | Proteina de enlace multivalente y multiespecifica que une a il-1 alfa y beta; conjugado que la comprende; acido nucleico que la codifica; vector; celula huesped; metodo de produccion; composicion farmaceutica que la comprende; y sus usos. | |
| WO2014028429A3 (en) | Enzymes and polymerases for the synthesis of rna | |
| MX390699B (es) | Composiciones y metodos para inhibicion de genes para apolipoproteina c-iii (apoc3). | |
| BRPI0908748A2 (pt) | Composições e métodos para análise de moléculas de ácido nucleico durante reações de amplificação | |
| EP4279610A3 (en) | Ribonucleic acid purification | |
| ATE502122T1 (de) | Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation | |
| BR112015023473A2 (pt) | mutações acetil-coa carboxilase | |
| EP4403632A3 (en) | Antisense nucleic acids | |
| EA201270019A1 (ru) | Двуцепочечная рнк, включенная в липидный состав и мишенью которой является ген pcsk9 | |
| EP2844261A4 (en) | SINA COMPOSITIONS | |
| BR112014030007A2 (pt) | minivetores superenrolados como uma ferramenta para reparação, alteração e substituição de dna | |
| MX391773B (es) | Variantes de lipasa y polinucleótidos que las codifican. | |
| BR112017013956B8 (pt) | Proteínas de fusão de citocinas | |
| BR112015021210A2 (pt) | métodos e composições para o direcionamento de rna polimerases e biogênese de rna não codificante para locais específicos | |
| BR112014016877A2 (pt) | ácidos nucleicos de ligação a c5a | |
| HK1199285A1 (en) | Compositions and methods for inducing apoptosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |